mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.09 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.09 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.09 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.09 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.09 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |